India Budget Offers Removal Of Excise Tax On 7,000 “Essential” Drugs
This article was originally published in PharmAsia News
India's government has prepared a budget for the coming year that calls for dropping the 16 percent excise tax on 7,000 drugs considered "essential" medicines. Removal of the tax, which is imposed on 57.5 percent of the maximum retail price of drugs, would mean about a 10 percent reduction in the 27 classes that make up drugs considered essential. Some individual drugs in that category are under price controls already. The nation's drug makers have agreed to pass the benefit of an end of the excise tax on to consumers of the "life-saving" drugs. (Click here for more
You may also be interested in...
The MHRA has been working all hours to ensure the standalone medtech UKCA mark works operationally and procedurally in the UK as of 1 January 2021.
Development Partners International, CDC Group and the European Bank for Reconstruction and Development have collaborated to create a “first of its kind, pan-African” generics platform built on the acquisition and combination of Egypt’s Adwia Pharmaceuticals and India’s Celon Laboratories. An initial $250m investment is to be followed by up to $500m in further funding.
Market Brief: Tissue-Engineered Wound Care Market Expected To Reach $1.9BN By 2024 Amid Rising Chronic Disease
The skin replacement market is led by three key players who have all been impacted by COVID-19, but the sector may see a quicker rebound than others as treatments cannot be deferred for a long time.